Interferon-α response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment

Figure 4 Antiviral effects of lamivudine in HepG2. 2.15 cells. A: HepG2.2.15 cells were cultivated with various concentrations (0 to 100 μmol/L) of 3 TC for 10 d. Then, supernatants were harvested and assayed for the presence of HBsAg and HBeAg by ELISA; B: HepG2.2.15 cells were treated with 2 or 20 μmol/L of lamivudine for 4, 7 and 10 d, respectively. Then, supernatants were collected and extracellular HBV-DNA was analyzed by dot blot hybridization; C: HepG2.2.15 cells were treated with various concentrations of lamivudine for 10 d. Then, intracellular HBV replicative intermediates were isolated for southern blotting. Lane 1: control, lane 2: 0.04 μmol/L, lane 3: 0.2 μmol/L, lane 4: 5 μmol/L, lane 5: 25 μmol/L, lane 6: 125 μmol/L, RC, relaxed circular HBV-DNA; DS, double stranded linear HBV-DNA.